CLINICAL_TRIALS trial_result · 2019-07-23

Clinical Trial Update: A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma [Phase 2]

Phase 2 study of LY2510924 in extensive-stage small cell lung carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Extensive Stage Small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-07-23